Literature DB >> 3005615

Effects of cyclosporin A on humoral immune response and resistance against vesicular stomatitis virus in mice.

S Charan, A W Huegin, A Cerny, H Hengartner, R M Zinkernagel.   

Abstract

The effect of cyclosporin A (CS-A) on the antiviral humoral response was studied by using vesicular stomatitis virus (VSV); VSV provided the opportunity to simultaneously assess both T-independent and T-dependent antibody responses. The T-independent anti-VSV immunoglobulin M (IgM) response was virtually unaffected, whereas the T-dependent primary anti-VSV IgG response was suppressed by CS-A; in contrast, the secondary IgG response was highly resistant to CS-A. Moreover, once the switch from IgM to IgG had occurred, the primary response also became refractory to suppression by CS-A. We concluded that the effect of CS-A on the primary anti-VSV antibody response was mediated via impairment of a T-dependent mechanism; in contrast, memory T cells or memory B cells or both were quite resistant to the suppressive effects of CS-A. CS-A treatment rendered mice highly susceptible to VSV infection; under CS-A treatment, mortality was 100% after infection via footpads, whereas immunocompetent mice survived. Since CS-A does not impair induction of early T-independent anti-VSV IgM neutralizing antibodies, this high mortality in CS-A treated mice illustrates the crucial role of CS-A-sensitive cells in resistance against VSV.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3005615      PMCID: PMC252848     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  34 in total

1.  Thymus dependence of viral antigens.

Authors:  W Burns; L C Billups; A L Notkins
Journal:  Nature       Date:  1975-08-21       Impact factor: 49.962

2.  Pathogenesis of vesicular stomatitis virus New Jersey infection in the adult hamster and mouse.

Authors:  M Bruno-Lobo; P H Peralta; G G Bruno-Lobo; D de Paola
Journal:  An Microbiol (Rio J)       Date:  1968

3.  Determination of total and merecaptothanol-resistant antibody in the same serum sample.

Authors:  D W Scott; R K Gershon
Journal:  Clin Exp Immunol       Date:  1970-02       Impact factor: 4.330

Review 4.  The effects of cyclosporin A on the immune system.

Authors:  E M Shevach
Journal:  Annu Rev Immunol       Date:  1985       Impact factor: 28.527

5.  Effects of the new anti-lymphocytic peptide cyclosporin A in animals.

Authors:  J F Borel; C Feurer; C Magnée; H Stähelin
Journal:  Immunology       Date:  1977-06       Impact factor: 7.397

6.  Activation of mouse lymphocytes by vesicular stomatitis virus.

Authors:  G W Goodman-Snitkoff; J J McSharry
Journal:  J Virol       Date:  1980-09       Impact factor: 5.103

7.  Cyclosporin A promotes spontaneous outgrowth in vitro of Epstein-Barr virus-induced B-cell lines.

Authors:  A G Bird; S M McLachlan; S Britton
Journal:  Nature       Date:  1981-01-22       Impact factor: 49.962

8.  Inability of mice to generate cytotoxic T lymphocytes to vesicular stomatitis virus restricted to H-2Kk or H-2Dk.

Authors:  K L Rosenthal; R M Zinkernagel
Journal:  J Immunol       Date:  1981-02       Impact factor: 5.422

9.  Mouse model for abortive rabies infection of the central nervous system.

Authors:  J S Smith
Journal:  Infect Immun       Date:  1981-01       Impact factor: 3.441

10.  Selective effects of cyclosporin A on functional B cell subsets in the mouse.

Authors:  A Kunkl; G G Klaus
Journal:  J Immunol       Date:  1980-12       Impact factor: 5.422

View more
  8 in total

1.  Distinct macrophage subpopulations regulate viral encephalitis but not viral clearance in the CNS.

Authors:  Christina D Steel; Woong-Ki Kim; Larry D Sanford; Laurie L Wellman; Sandra Burnett; Nico Van Rooijen; Richard P Ciavarra
Journal:  J Neuroimmunol       Date:  2010-09-14       Impact factor: 3.478

2.  Human CD4-major histocompatibility complex class II (DQw6) transgenic mice in an endogenous CD4/CD8-deficient background: reconstitution of phenotype and human-restricted function.

Authors:  R S Yeung; J M Penninger; T M Kündig; Y Law; K Yamamoto; N Kamikawaji; L Burkly; T Sasazuki; R Flavell; P S Ohashi; T W Mak
Journal:  J Exp Med       Date:  1994-11-01       Impact factor: 14.307

3.  Changes in humoral immune response after SARS-CoV-2 infection in liver transplant recipients compared to immunocompetent patients.

Authors:  Aránzazu Caballero-Marcos; Magdalena Salcedo; Roberto Alonso-Fernández; Manuel Rodríguez-Perálvarez; María Olmedo; Javier Graus Morales; Valentín Cuervas-Mons; Alba Cachero; Carmelo Loinaz-Segurola; Mercedes Iñarrairaegui; Lluís Castells; Sonia Pascual; Carmen Vinaixa-Aunés; Rocío González-Grande; Alejandra Otero; Santiago Tomé; Javier Tejedor-Tejada; José María Álamo-Martínez; Luisa González-Diéguez; Flor Nogueras-Lopez; Gerardo Blanco-Fernández; Gema Muñoz-Bartolo; Francisco Javier Bustamante; Emilio Fábrega; Mario Romero-Cristóbal; Rosa Martin-Mateos; Julia Del Rio-Izquierdo; Ana Arias-Milla; Laura Calatayud; Alberto A Marcacuzco-Quinto; Víctor Fernández-Alonso; Concepción Gómez-Gavara; Jordi Colmenero; Patricia Muñoz; José A Pons
Journal:  Am J Transplant       Date:  2021-04-27       Impact factor: 9.369

4.  Induction of protective cytotoxic T cell responses in the presence of high titers of virus-neutralizing antibodies: implications for passive and active immunization.

Authors:  P Seiler; M A Bründler; C Zimmermann; D Weibel; M Bruns; H Hengartner; R M Zinkernagel
Journal:  J Exp Med       Date:  1998-02-16       Impact factor: 14.307

5.  T cell-independent antibody-mediated clearance of polyoma virus in T cell-deficient mice.

Authors:  E Szomolanyi-Tsuda; R M Welsh
Journal:  J Exp Med       Date:  1996-02-01       Impact factor: 14.307

6.  Improvement of Antitumor Therapies Based on Vaccines and Immune-Checkpoint Inhibitors by Counteracting Tumor-Immunostimulation.

Authors:  Paula Chiarella; Mónica Vermeulen; Daniela R Montagna; Pablo Vallecorsa; Ariel Ramiro Strazza; Roberto P Meiss; Oscar D Bustuoabad; Raúl A Ruggiero; Richmond T Prehn
Journal:  Front Oncol       Date:  2018-01-26       Impact factor: 6.244

7.  Effect of cyclosporin A on an experimental chronic viral infection of the central nervous system.

Authors:  O Boespflug; C Godfraind; M Tardieu
Journal:  J Neuroimmunol       Date:  1989-01       Impact factor: 3.478

8.  Morphologic and functional effects of gamma secretase inhibition on splenic marginal zone B cells.

Authors:  Maria Cristina de Vera Mudry; Franziska Regenass-Lechner; Laurence Ozmen; Bernd Altmann; Matthias Festag; Thomas Singer; Lutz Müller; Helmut Jacobsen; Alexander Flohr
Journal:  Int J Alzheimers Dis       Date:  2012-12-17
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.